Circulating CD4+ T-cell number decreases in rheumatoid patients with clinical response to rituximab

被引：0
|
作者：
Silvia Piantoni
Mirko Scarsi
Angela Tincani
Paolo Airò
机构：
[1] Spedali Civili and University of Brescia,Rheumatology and Clinical Immunology
[2] University of Pavia,Rheumatology Chair
[3] Spedali Civili of Brescia,Rheumatology and Clinical Immunology Unit
来源：
Rheumatology International | 2015年 / 35卷
关键词：
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Rheumatoid Factor; Opportunistic Infection; Absolute Cell Count;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1571 / 1573
页数：2
相关论文
共 50 条
  • [1] Circulating CD4+T-cell number decreases in rheumatoid patients with clinical response to rituximab
    Piantoni, Silvia
    Scarsi, Mirko
    Tincani, Angela
    Airo, Paolo
    [J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (09) : 1571 - 1573
  • [2] Development of circulating CD4+ T-cell memory
    Soon, Megan S. F.
    Engel, Jessica A.
    Lee, Hyun J.
    Haque, Ashraful
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2019, 97 (07): : 617 - 624
  • [3] Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
    Matthieu Lavielle
    Denis Mulleman
    Philippe Goupille
    Clément Bahuaud
    Hsueh Cheng Sung
    Hervé Watier
    Gilles Thibault
    [J]. Arthritis Research & Therapy, 18
  • [4] The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire
    Pourgheysari, Batoul
    Khan, Naeem
    Best, Donna
    Bruton, Rachel
    Nayak, Laxman
    Moss, Paul A. H.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (14) : 7759 - 7765
  • [5] RITUXIMAB-INDUCED T-CELL DEPLETION IN PATIENTS WITH RHEUMATOID ARTHRITIS: ASSOCIATION WITH CLINICAL RESPONSE
    Melet, J.
    Mulleman, D.
    Goupille, P.
    Ribourtout, B.
    Watier, H.
    Thibault, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 614 - 614
  • [6] CORRELATION OF RHEUMATOID-FACTOR LEVEL WITH THE NUMBER OF CD4+ CIRCULATING LYMPHOCYTES-T IN RHEUMATOID-ARTHRITIS PATIENTS
    REME, T
    PORTIER, M
    BROCHIER, J
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1989, 32 (04): : 505 - 506
  • [7] CMV reactivation and specific CD4+ T-cell response in patients with septic shock
    van Muller, L
    Klemm, A
    Durmus, N
    Schneider, M
    Weiss, M
    Wiedeck, H
    Georgieff, M
    Mertens, T
    [J]. SHOCK, 2004, 21 : 110 - 110
  • [8] The α4 Nicotinic Receptor Promotes CD4+ T-Cell Proliferation and a Helper T-Cell Immune Response
    Nordman, Jacob C.
    Muldoon, Pretal
    Clark, Sarah
    Damaj, M. Imad
    Kabbani, Nadine
    [J]. MOLECULAR PHARMACOLOGY, 2014, 85 (01) : 50 - 61
  • [9] Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
    García, F
    de Lazzari, E
    Plana, M
    Castro, P
    Mestre, G
    Nomdedeu, M
    Fumero, E
    Martínez, E
    Mallolas, J
    Blanco, JL
    Miró, JM
    Pumarola, T
    Gallart, T
    Gatell, JM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 702 - 713
  • [10] Therapy with infliximab decreases the CD4+ CD28- T cell compartment in peripheral blood in patients with rheumatoid arthritis
    Pawlik, A
    Ostanek, L
    Brzosko, W
    Brzosko, M
    Masiuk, M
    Machalinski, B
    Szklarz, BG
    [J]. RHEUMATOLOGY INTERNATIONAL, 2004, 24 (06) : 351 - 354
12345